Literature DB >> 25580410

Effect of laparoscopic surgery on the initiation and completion of chemotherapy in patients with colon cancer.

Min-Ki Kim1, Won-Kyung Kang1.   

Abstract

Entities:  

Year:  2014        PMID: 25580410      PMCID: PMC4286770          DOI: 10.3393/ac.2014.30.6.250

Source DB:  PubMed          Journal:  Ann Coloproctol        ISSN: 2287-9714


× No keyword cloud information.
See Article on Page 274-279 The developments in colon cancer treatment over the past two decades can be found largely in chemotherapy and laparoscopic surgery. Adjuvant chemotherapy increases survival in stage III and select stage II colon cancer patients [1, 2]. Reports in the literature have indicated that delaying the initiation of adjuvant chemotherapy for longer than eight weeks after surgery or after failure to complete adjuvant chemotherapy adversely affects the overall survival of colon cancer patients [3, 4]. Laparoscopic surgery has several benefits in cosmesis, postoperative length of hospital stay, analgesics usage and return of bowel function while it is comparable in survival to open surgery. Therefore, many large-volume centers use laparoscopic surgery as the mainstay in colon cancer treatment. However, few studies deal with the effect of laparoscopic surgery on the initiation or completion of adjuvant chemotherapy in colon cancer patients. In a previous study [5], only 67% of patients were reported to have completed their chemotherapy. If those effects of laparoscopic surgery are proven, some chance may exist to improve colon cancer survival by increasing compliance with chemotherapy. Recently, Gantt Jr et al. [6] reported no difference in proportions of patients who received adjuvant chemotherapy more than eight weeks after surgery between the laparoscopic and the open surgery groups. Their notable finding was that the delay in the initiation of adjuvant chemotherapy adversely affected patients' disease-free and overall survival in the open surgery group, but not in both of the laparoscopic surgery group. Although the article has several limitations and shortcomings, vague follow-up period, uncertainty of whether cancer-specific survival was calculated or not, unclear relationship between chemotherapy completion rate and survival, no significant difference in the chemotherapy completion rate and a significant difference in survival rate between the laparoscopic surgery and the open surgery groups were noted [7]. Further studies dealing with the issue of laparoscopic surgery and chemotherapy compliance are expected to be spurred by the publication of this study.
  7 in total

Review 1.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.

Authors:  James J Biagi; Michael J Raphael; William J Mackillop; Weidong Kong; Will D King; Christopher M Booth
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

2.  Comparison of compliance of adjuvant chemotherapy between laparoscopic and open surgery in patients with colon cancer.

Authors:  Kan Ho Chun; Byung Noe Bae; Hoon An; Hyeonseok Jeong; Hyunjin Cho; Geumhee Gwak; Keun Ho Yang; Ki Hwan Kim; Hong Ju Kim; Young Duk Kim
Journal:  Ann Coloproctol       Date:  2014-12-31

3.  Completion of therapy by Medicare patients with stage III colon cancer.

Authors:  Sharon A Dobie; Laura-Mae Baldwin; Jason A Dominitz; Barbara Matthews; Kevin Billingsley; William Barlow
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

4.  Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.

Authors:  L G M van der Geest; J E A Portielje; M W J M Wouters; N I Weijl; B C Tanis; R A E M Tollenaar; H Struikmans; J W R Nortier
Journal:  Colorectal Dis       Date:  2013       Impact factor: 3.788

5.  Laparoscopy mitigates adverse oncological effects of delayed adjuvant chemotherapy for colon cancer.

Authors:  Gerald A Gantt; Jean Ashburn; Ravi P Kiran; Alok A Khorana; Matthew F Kalady
Journal:  Surg Endosc       Date:  2015-02       Impact factor: 4.584

6.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

7.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Authors:  Richard Gray; Jennifer Barnwell; Christopher McConkey; Robert K Hills; Norman S Williams; David J Kerr
Journal:  Lancet       Date:  2007-12-15       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.